Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
38.95
+0.51 (1.33%)
At close: Sep 15, 2026, 4:00 PM EDT
40.00
+1.05 (2.70%)
After-hours: Sep 15, 2026, 7:39 PM EDT
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $2.78 billion as of September 15, 2026. Its market cap has increased by 130.62% in one year.
Market Cap
2.78B
Enterprise Value
1.44B
1-Year Change
130.62%
Ranking
Category
Stock Price
$38.95
ChartMarket Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $2.78B, an increase of 406.09%. That is a compound annual growth rate of 56.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 2.78B | -42.24% |
| Dec 31, 2025 | 4.81B | 209.65% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
| Feb 3, 2023 | 548.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arcutis Biotherapeutics | 3.00B |
| Celldex Therapeutics | 2.90B |
| MBX Biosciences | 2.84B |
| Immunome | 2.80B |
| AtaiBeckley | 2.73B |
| NewAmsterdam Pharma Company | 2.73B |
| Zai Lab | 2.71B |
| Disc Medicine | 2.69B |